Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Gross Profit (2020 - 2025)

Bioventus (BVS) has disclosed Gross Profit for 6 consecutive years, with $108.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 5.97% year-over-year to $108.8 million, compared with a TTM value of $388.2 million through Dec 2025, changed 0.02%, and an annual FY2025 reading of $388.2 million, changed 0.02% over the prior year.
  • Gross Profit was $108.8 million for Q4 2025 at Bioventus, up from $94.2 million in the prior quarter.
  • Across five years, Gross Profit topped out at $108.8 million in Q4 2025 and bottomed at $59.6 million in Q2 2021.
  • Average Gross Profit over 5 years is $86.9 million, with a median of $87.0 million recorded in 2021.
  • The sharpest move saw Gross Profit surged 89.13% in 2021, then decreased 15.47% in 2022.
  • Year by year, Gross Profit stood at $87.8 million in 2021, then fell by 15.47% to $74.2 million in 2022, then increased by 16.33% to $86.3 million in 2023, then increased by 18.95% to $102.7 million in 2024, then grew by 5.97% to $108.8 million in 2025.
  • Business Quant data shows Gross Profit for BVS at $108.8 million in Q4 2025, $94.2 million in Q3 2025, and $102.1 million in Q2 2025.